10.40 | 7.40 – Expertise Panelist Discussion: The Additive Role of CTCs & ctDNA in Your Clinical Development Strategy

Time: 10:40 am
day: Day Two

Details:

  • Complementing your biomarker evaluation with CTCs
  • Comprehensive cancer profiling: CTCs and ctDNA
  • Banking the remnant plasma and slides for future analysis

Speakers: